Screening for Hepatitis B, Hepatitis C and AIDS Viruses Using Dried Blood Spot (BUVARD)

University Hospital, Rouen

Status: Unknown

Conditions: AIDS; Hepatitis C; Hepatitis B

Treatments: Diagnostic Test: Blood collection using Dried Blood Spot

Study type: Interventional

Funder types: Other

Identifiers

NCT05390424

2021/098/HP

Details and patient eligibility

About

The aim of the study is to screen for hepatitis B, hepatitis C and AIDS viruses using a Dried Blood Spot in drug users

Enrollment: 500 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Former or active intravenous and/or nasal drug user
• Person on opiate substitution therapy

Exclusion criteria

• Person with known active viral infection(s)

Trial design

Primary purpose: Diagnostic

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

500 participants in 1 patient group

Drug user

Experimental group

Description:

Drug users will be screened for Hepatitis C, Hepatitis B and AIDS using Dried Blood Spot for blood collection

Treatment:

Diagnostic Test: Blood collection using Dried Blood Spot